SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-207610
Filing Date
2021-07-02
Accepted
2021-07-02 16:10:57
Documents
14
Period of Report
2021-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193521d8k.htm   iXBRL 8-K 26801
2 EX-99.1 d193521dex991.htm EX-99.1 3781
6 GRAPHIC g193521g0702223235878.jpg GRAPHIC 3247
  Complete submission text file 0001193125-21-207610.txt   163595

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210630.xsd EX-101.SCH 2897
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210630_lab.xml EX-101.LAB 18839
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210630_pre.xml EX-101.PRE 11842
7 EXTRACTED XBRL INSTANCE DOCUMENT d193521d8k_htm.xml XML 3598
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 211070108
SIC: 2835 In Vitro & In Vivo Diagnostic Substances